*OPENAI-BACKED BIO-DEFENSE STARTUP TO BEGIN HUMAN CLINICAL TRIALS OF ANTIBODY DRUGS NEXT YR, CO SAYS: WSJ

2026-09-28 00:00:09 UTC · Tradfin · Equation TradFi